Telmisartan to protect the heart during breast cancer chemotherapy
Treatments studied
Part of Cancer, Skin clinical trials.
This study tests whether a blood pressure pill, telmisartan, can protect the heart during chemotherapy for breast cancer. It may help reduce the risk of heart damage caused by doxorubicin (a common chemo drug).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 to 65.
- You have just been diagnosed with breast cancer and have not received chemotherapy yet.
- A recent heart ultrasound shows your heart's pumping ability is at least 55%.
- You do not have a history of serious heart disease, liver or kidney problems, or inflammatory conditions.
- You are not taking blood pressure medications called ACE inhibitors or ARBs.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a daily pill called dapagliflozin can help protect the heart from damage caused by doxorubicin chemotherapy in people being treated for early-stage breast cancer. If you are starting doxorubicin and have a healthy heart, this might lower your risk of heart problems later.
This trial tests whether two different diabetes drugs (SGLT-2 inhibitors and DPP-4 inhibitors) can help prevent heart damage that anthracycline chemotherapy can cause in breast cancer patients. You would receive one of the two drugs during your treatment to see if it protects your heart.
This trial checks how well the heart handles anthracycline chemotherapy in breast cancer patients. It helps doctors find early signs of heart side effects so they can keep you safe during treatment.
This trial tests sacubitril/valsartan to help prevent heart weakness (cardiotoxicity) caused by breast cancer treatments like anthracyclines and/or anti-HER2 drugs. If you qualify, you may be offered this heart-protection medicine while your cancer is treated.
This study tests whether careful blood pressure management can help protect the heart during certain types of chemotherapy (anthracyclines) for breast cancer. Participants will use a smart blood pressure device and may also do an exercise test.
This trial tests whether taking the cholesterol-lowering drug rosuvastatin can protect your heart from damage caused by a common type of chemotherapy called anthracyclines. It may help reduce the risk of heart problems during breast cancer treatment.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.